TALPHERA, INC. — Director's Dealing 2015

Jun 24, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACELRX PHARMACEUTICALS INC (ACRX)
CIK: 0001427925
Period of Report: 2015-06-23

Reporting Person: WAN MARK A (Director, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-23	Common Stock (Option to Buy)	$4.08	A	15000	Acquired	2025-06-22	Common Stock (15000)	Direct

Footnotes

F1: Issued pursuant to the 2011 Equity Incentive Plan.

F2: 100% Acceleration upon Change of Control.

F3: The shares subject to the option vest as follows: 1/24th of the shares subject to the option vest in equal monthly installments over 24 months, subject to Optionee's Continuous Service on the Company's Board of Directors.